ArticleJournal of neurology2020
Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2.
Article in Journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed.
- Impact of COVID-19 pandemic and lockdown in a cohort of myasthenia gravis patients in India.Clinical neurology and neurosurgery · 2021Trial
- The effect of applying the nursing process based on the Theory of Goal Attainment on activities of daily living and quality of life in persons with multiple sclerosis during COVID-19 pandemic: a clinical trial.Irish journal of medical science · 2023Article
- Potential treatments of COVID-19: Drug repurposing and therapeutic interventions.Journal of pharmacological sciences · 2023Review
- Comprehensive Investigations Relationship Between Viral Infections and Multiple Sclerosis Pathogenesis.Current microbiology · 2022Review
- The impact of COVID-19 on patients with neurological disorders and their access to healthcare in Africa: A review of the literature.Brain and behavior · 2022Review
- SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19.Journal of neurology · 2022Review
- Thermal dysregulation in patients with multiple sclerosis during SARS-CoV-2 infection. The potential therapeutic role of exercise.Multiple sclerosis and related disorders · 2022Review
- The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.Cellular & molecular biology letters · 2022Review
- Multiple sclerosis patients' response to COVID-19 pandemic and vaccination in Egypt.The Egyptian journal of neurology, psychiatry and neurosurgery · 2022Article
- Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha.Frontiers in oncology · 2022Review
- Risk and outcomes of COVID-19 in patients with multiple sclerosis.European journal of neurology · 2021Article
- Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.Molecular neurobiology · 2021Review
- COVID-19 severity and outcome in multiple sclerosis: Results of a national, registry-based, matched cohort study.Multiple sclerosis and related disorders · 2021Article
- Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies.Multiple sclerosis and related disorders · 2021Article
- Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.Multiple sclerosis and related disorders · 2021Observational
- The effect of the Australian bushfires and the COVID-19 pandemic on health behaviours in people with multiple sclerosis.Multiple sclerosis and related disorders · 2021Article
- Nervous System Involvement in COVID-19: a Review of the Current Knowledge.Molecular neurobiology · 2021Review
- Genetic Diversity of SARS-CoV2 and Environmental Settings: Possible Association with Neurological Disorders.Molecular neurobiology · 2021Review
- SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis.Diseases (Basel, Switzerland) · 2021Review
- Neurological manifestations of COVID-19 in confirmed and probable cases: A descriptive study from a large tertiary care center.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2021Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.